LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 55.48 | 84.90 | 1935 | 6567 | 0.2946 | 0.6460 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 55.48 | 84.90 | 398 | 6567 | 0.0606 | 0.2793 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 55.48 | 84.90 | 2341 | 6567 | 0.3564 | 0.6967 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 57.18 | 84.90 | 134 | 6963 | 0.0192 | 0.0744 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 57.18 | 84.90 | 2001 | 6963 | 0.2874 | 0.6438 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 57.18 | 84.90 | 435 | 6963 | 0.0625 | 0.2930 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 57.18 | 84.90 | 2427 | 6963 | 0.3485 | 0.6945 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.88 | 84.90 | 181 | 7291 | 0.0248 | 0.1251 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.88 | 84.90 | 2071 | 7291 | 0.2840 | 0.6441 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.88 | 84.90 | 383 | 7291 | 0.0525 | 0.2643 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.88 | 84.90 | 2482 | 7291 | 0.3404 | 0.6911 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 60.59 | 84.90 | 179 | 7641 | 0.0234 | 0.1218 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 60.59 | 84.90 | 2171 | 7641 | 0.2841 | 0.6476 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 60.59 | 84.90 | 409 | 7641 | 0.0535 | 0.2740 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 60.59 | 84.90 | 2598 | 7641 | 0.3400 | 0.6938 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 62.29 | 84.90 | 182 | 7934 | 0.0229 | 0.1236 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 62.29 | 84.90 | 2281 | 7934 | 0.2875 | 0.6532 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 62.29 | 84.90 | 442 | 7934 | 0.0557 | 0.2866 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 62.29 | 84.90 | 2745 | 7934 | 0.3460 | 0.7006 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.99 | 84.90 | 229 | 8212 | 0.0279 | 0.1623 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.99 | 84.90 | 2386 | 8212 | 0.2905 | 0.6582 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.99 | 84.90 | 461 | 8212 | 0.0561 | 0.2924 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.99 | 84.90 | 2863 | 8212 | 0.3486 | 0.7047 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 65.70 | 84.90 | 233 | 8484 | 0.0275 | 0.1641 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 65.70 | 84.90 | 2482 | 8484 | 0.2925 | 0.6622 | MN20160318_Q02 | F13 |